留美医学博士，入选上海市医苑新星、上海市青年科技英才扬帆计划、太阳成集团附属第十人民医院攀登人才计划。擅长肝癌、转移性肝癌、胰腺癌等实体肿瘤及急性消化道出血的介入治疗。主持国家自然科学基金1项，主持上海市卫健委、市科委、太阳成集团课题多项；以第一作者发表医学论文多篇；晚期胰腺癌介入治疗项目荣获2016年上海市科技进步一等奖1项（10/15）。
主持科研项目：
2020年上海市卫健委临床研究专项，预防性动脉栓塞治疗血管造影阴性急性上消化道出血的安全性及疗效探索，20204Y0167；
2020年太阳成集团智库研究专项基金，信息技术辅助的长三角区域医疗水平同质化可行性研究；
2019年国家自然基金（81801805）外泌体源性lncRNA DDX6P调控胰腺癌灌注化疗耐药的功能和机制研究；
2018年太阳成集团附属第十人民医院攀登人才计划，综合介入治疗晚期胰腺癌的临床策略优化研究；
2017年太阳成集团“中央高校基本科研业务专项资金”基础研究能力提升计划，1501219145，miR128靶向调控Hedgehog在胰腺癌转移机制中的研究。
代表性论著
Han S, Cao C, Yuan Y, et al. Transcatheter Arterial Infusion Combined With Radioactive Particles in the Treatment of Advanced Body/Tail Pancreatic Cancer: A Retrospective Cohort Study. Pancreas. 2021;50(6):822-826.
Cao C*, Han S*, Yuan Y, Wu Y, Lian W, Zhang X, Pan L, Li M. Downregulated Circular RNA hsa_circ_0000291 Suppresses Migration And Proliferation Of Gastric Cancer Via Targeting The miR-183/ITGB1 Axis. Cancer Manag Res. 2019. 14;11:9675-9683.
Han S, Zhang X, Li M. Research and application progress in PLGA embolic microspheres. Frontiers in Bioscience 2016, June 1(21), 1102-1109.
Han S, Cao C, Li M et al. ROBO3 Promotes Growth and Metastasis of Pancreatic Carcinoma. Cancer Lett. 2015 Sep 28;366(1):61- 70
韩世龙, 朱晓黎，张猛等. 经皮注射医用臭氧治疗兔VX2移植瘤的实验研究. 介入放射学杂志, 2013, 22(3): 227-231.
Medical Doctor visiting in the United States, selected as Shanghai Medical Rising Star, Shanghai Youth Science and Technology Talents Sailing Program, and the Rising Talent Program of the Tenth People's Hospital Affiliated to Tongji University. He is good at interventional treatment of solid tumors such as liver cancer, metastatic liver cancer, pancreatic cancer, and acute gastrointestinal bleeding and hemoptysis. Presided over 1 National Natural Science Foundation of China, a number of projects of Shanghai Municipal Health Commission, Municipal Science and Technology Commission, and Tongji University; published many medical papers as the first author; interventional treatment for advanced pancreatic cancer project won the 2016 Shanghai Prize for Science and Technology Progress First Class (10/15).
Hosting scientific research projects:
1. 2020 Shanghai Municipal Health Commission's clinical research project, The safety and efficacy of preventive arterial embolization in the treatment of acute upper gastrointestinal bleeding with negative angiography, 20204Y0167;
2. 2020 Tongji University Think Tank Research Special Fund, Information technology-assisted feasibility study on the homogeneity of medical care in the Yangtze River Delta region;
3. In 2019, the National Natural Science Foundation of China (81801805) exosome-derived lncRNA DDX6P regulates the function and mechanism of pancreatic cancer infusion chemotherapy resistance;
4. In 2018, The Rising Talents Program of the Tenth People's Hospital Affiliated to Tongji University, Comprehensive interventional treatment of advanced pancreatic cancer clinical strategy optimization research;
5. In 2017, Tongji University's "Special Fund for Fundamental Scientific Research for Central Universities" basic research capacity improvement plan, 1501219145, miR128 targeted regulation of Hedgehog in the mechanism of pancreatic cancer metastasis.
